Creating a translational genomic framework for canine osteosarcoma: updates on the NCI DOG2 project

Описание к видео Creating a translational genomic framework for canine osteosarcoma: updates on the NCI DOG2 project

Dr. Amy LeBlanc is a board-certified veterinary oncologist, Senior Scientist and Director of the CCR Comparative Oncology Program at the National Cancer Institute, NIH. In this position, she directly oversees and manages the operations of the Comparative Oncology Trials Consortium (COTC), which designs and executes clinical trials of new cancer therapies in tumor-bearing pet dogs. She joins us on OsteoBites to discuss findings as we work toward genomic and transcriptional profiling of canine osteosarcoma and how the results relate to human osteosarcoma. The DOG2 project was launched to better understand the relationships between the disease in dogs and humans -- all to make it better for all patients, be they 2-legged or 4 legged!

Комментарии

Информация по комментариям в разработке

Похожие видео